Skip to main content
Erschienen in: Quality of Life Research 8/2015

01.08.2015

Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD)

verfasst von: Noelle E. Carlozzi, Anna L. Kratz, Nancy R. Downing, Siera Goodnight, Jennifer A. Miner, Nicholas Migliore, Jane S. Paulsen

Erschienen in: Quality of Life Research | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The reliability and construct validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) were examined in individuals with Huntington disease (HD).

Methods

We examined factor structure (confirmatory factor analysis), internal consistency reliability (Cronbach’s alpha), floor and ceiling effects, convergent validity (Pearson correlations), and known-groups validity (multivariate analysis).

Results

Results of a confirmatory factor analysis replicated the six-factor latent model that reflects the six separate scales within the WHODAS 2.0 (understanding and communicating; getting around; self-care; getting along with others; life activities; participation). Cronbach’s alpha for the scale was 0.94, suggesting good internal consistency reliability. The WHODAS demonstrated a ceiling effect for 19.5 % of participants; there were no floor effects. There was evidence for convergent validity; the WHODAS demonstrated moderate significant correlations with other general measures of health-related quality of life (HRQOL; i.e., RAND-12, EQ5D). Multivariate analyses indicated that late-stage HD participants indicated poorer HRQOL than both early-stage HD and prodromal HD participants for all HRQOL measures.

Conclusions

Findings provide support for both the reliability and validity of the WHODAS 2.0 in individuals with HD.
Literatur
1.
Zurück zum Zitat Ustun, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.PubMedCentralPubMedCrossRef Ustun, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Rehm, J., Ustun, B., Saxena, S., Nelson, C. B., Chatterji, S., Ivis, F., & Adlaf, E. (2006). On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. International Journal of Methods in Psychiatric Research, 8(2), 110–122.CrossRef Rehm, J., Ustun, B., Saxena, S., Nelson, C. B., Chatterji, S., Ivis, F., & Adlaf, E. (2006). On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. International Journal of Methods in Psychiatric Research, 8(2), 110–122.CrossRef
3.
Zurück zum Zitat Scorza, P., Stevenson, A., Canino, G., Mushashi, C., Kanyanganzi, F., Munyanah, M., & Betancourt, T. (2013). Validation of the “World Health Organization Disability Assessment Schedule for children, WHODAS-Child” in Rwanda. PLoS ONE, 8(3), e57725.PubMedCentralPubMedCrossRef Scorza, P., Stevenson, A., Canino, G., Mushashi, C., Kanyanganzi, F., Munyanah, M., & Betancourt, T. (2013). Validation of the “World Health Organization Disability Assessment Schedule for children, WHODAS-Child” in Rwanda. PLoS ONE, 8(3), e57725.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Posl, M., Cieza, A., & Stucki, G. (2007). Psychometric properties of the WHODASII in rehabilitation patients. Quality of Life Research, 16(9), 1521–1531.PubMedCrossRef Posl, M., Cieza, A., & Stucki, G. (2007). Psychometric properties of the WHODASII in rehabilitation patients. Quality of Life Research, 16(9), 1521–1531.PubMedCrossRef
5.
Zurück zum Zitat Garin, O., Ayuso-Mateos, J. L., Almansa, J., Nieto, M., Chatterji, S., Vilagut, G., et al. (2010). Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes, 8, 51.PubMedCentralPubMedCrossRef Garin, O., Ayuso-Mateos, J. L., Almansa, J., Nieto, M., Chatterji, S., Vilagut, G., et al. (2010). Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes, 8, 51.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Federici, S., Meloni, F., Mancini, A., Lauriola, M., & Olivetti Belardinelli, M. (2009). World Health Organisation Disability Assessment Schedule II: Contribution to the Italian validation. Disability and Rehabilitation, 31(7), 553–564.PubMedCrossRef Federici, S., Meloni, F., Mancini, A., Lauriola, M., & Olivetti Belardinelli, M. (2009). World Health Organisation Disability Assessment Schedule II: Contribution to the Italian validation. Disability and Rehabilitation, 31(7), 553–564.PubMedCrossRef
7.
Zurück zum Zitat Kulnik, S. T., & Nikoletou, D. (2014). WHODAS 2.0 in community rehabilitation: A qualitative investigation into the validity of a generic patient-reported measure of disability. Disability and Rehabilitation, 36(2), 146–154.PubMedCrossRef Kulnik, S. T., & Nikoletou, D. (2014). WHODAS 2.0 in community rehabilitation: A qualitative investigation into the validity of a generic patient-reported measure of disability. Disability and Rehabilitation, 36(2), 146–154.PubMedCrossRef
8.
Zurück zum Zitat McArdle, R., Chisolm, T. H., Abrams, H. B., Wilson, R. H., & Doyle, P. J. (2005). The WHO-DAS II: Measuring outcomes of hearing aid intervention for adults. Trends Amplif, 9(3), 127–143.PubMedCentralPubMedCrossRef McArdle, R., Chisolm, T. H., Abrams, H. B., Wilson, R. H., & Doyle, P. J. (2005). The WHO-DAS II: Measuring outcomes of hearing aid intervention for adults. Trends Amplif, 9(3), 127–143.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Chisolm, T. H., Abrams, H. B., McArdle, R., Wilson, R. H., & Doyle, P. J. (2005). The WHO-DAS II: Psychometric properties in the measurement of functional health status in adults with acquired hearing loss. Trends in Amplification, 9(3), 111–126.PubMedCentralPubMedCrossRef Chisolm, T. H., Abrams, H. B., McArdle, R., Wilson, R. H., & Doyle, P. J. (2005). The WHO-DAS II: Psychometric properties in the measurement of functional health status in adults with acquired hearing loss. Trends in Amplification, 9(3), 111–126.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Baron, M., Schieir, O., Hudson, M., Steele, R., Kolahi, S., Berkson, L., et al. (2008). The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. Arthritis and Rheumatism, 59(3), 382–390.PubMedCrossRef Baron, M., Schieir, O., Hudson, M., Steele, R., Kolahi, S., Berkson, L., et al. (2008). The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. Arthritis and Rheumatism, 59(3), 382–390.PubMedCrossRef
11.
Zurück zum Zitat Meesters, J. J., Verhoef, J., Liem, I. S., Putter, H., & Vliet Vlieland, T. P. (2010). Validity and responsiveness of the World Health Organization Disability Assessment Schedule II to assess disability in rheumatoid arthritis patients. Rheumatology (Oxford), 49(2), 326–333.CrossRef Meesters, J. J., Verhoef, J., Liem, I. S., Putter, H., & Vliet Vlieland, T. P. (2010). Validity and responsiveness of the World Health Organization Disability Assessment Schedule II to assess disability in rheumatoid arthritis patients. Rheumatology (Oxford), 49(2), 326–333.CrossRef
12.
Zurück zum Zitat Kutlay, S., Kucukdeveci, A. A., Elhan, A. H., Oztuna, D., Koc, N., & Tennant, A. (2011). Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis. Rheumatology International, 31(3), 339–346.PubMedCrossRef Kutlay, S., Kucukdeveci, A. A., Elhan, A. H., Oztuna, D., Koc, N., & Tennant, A. (2011). Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis. Rheumatology International, 31(3), 339–346.PubMedCrossRef
13.
Zurück zum Zitat Hudson, M., Steele, R., Taillefer, S., & Baron, M. (2008). Quality of life in systemic sclerosis: Psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis and Rheumatism, 59(2), 270–278.PubMedCrossRef Hudson, M., Steele, R., Taillefer, S., & Baron, M. (2008). Quality of life in systemic sclerosis: Psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis and Rheumatism, 59(2), 270–278.PubMedCrossRef
14.
Zurück zum Zitat Noonan, V. K., Kopec, J. A., Noreau, L., Singer, J., Masse, L. C., & Dvorak, M. F. (2010). Comparing the reliability of five participation instruments in persons with spinal conditions. Journal of Rehabilitation Medicine, 42(8), 735–743.PubMedCrossRef Noonan, V. K., Kopec, J. A., Noreau, L., Singer, J., Masse, L. C., & Dvorak, M. F. (2010). Comparing the reliability of five participation instruments in persons with spinal conditions. Journal of Rehabilitation Medicine, 42(8), 735–743.PubMedCrossRef
15.
Zurück zum Zitat Wolf, A. C., Tate, R. L., Lannin, N. A., Middleton, J., Lane-Brown, A., & Cameron, I. D. (2012). The World Health Organization Disability Assessment Scale, WHODAS II: Reliability and validity in the measurement of activity and participation in a spinal cord injury population. Journal of Rehabilitation Medicine, 44(9), 747–755.PubMedCrossRef Wolf, A. C., Tate, R. L., Lannin, N. A., Middleton, J., Lane-Brown, A., & Cameron, I. D. (2012). The World Health Organization Disability Assessment Scale, WHODAS II: Reliability and validity in the measurement of activity and participation in a spinal cord injury population. Journal of Rehabilitation Medicine, 44(9), 747–755.PubMedCrossRef
16.
Zurück zum Zitat Noonan, V. K., Kopec, J. A., Noreau, L., Singer, J., Masse, L. C., Zhang, H., & Dvorak, M. F. (2010). Comparing the validity of five participation instruments in persons with spinal conditions. Journal of Rehabilitation Medicine, 42(8), 724–734.PubMedCrossRef Noonan, V. K., Kopec, J. A., Noreau, L., Singer, J., Masse, L. C., Zhang, H., & Dvorak, M. F. (2010). Comparing the validity of five participation instruments in persons with spinal conditions. Journal of Rehabilitation Medicine, 42(8), 724–734.PubMedCrossRef
17.
Zurück zum Zitat Schlote, A., Richter, M., Wunderlich, M. T., Poppendick, U., Moller, C., Schwelm, K., & Wallesch, C. W. (2009). WHODAS II with people after stroke and their relatives. Disability and Rehabilitation, 31(11), 855–864.PubMedCrossRef Schlote, A., Richter, M., Wunderlich, M. T., Poppendick, U., Moller, C., Schwelm, K., & Wallesch, C. W. (2009). WHODAS II with people after stroke and their relatives. Disability and Rehabilitation, 31(11), 855–864.PubMedCrossRef
18.
Zurück zum Zitat Kucukdeveci, A. A., Kutlay, S., Yildizlar, D., Oztuna, D., Elhan, A. H., & Tennant, A. (2013). The reliability and validity of the World Health Organization Disability Assessment Schedule (WHODAS-II) in stroke. Disability and Rehabilitation, 35(3), 214–220.PubMedCrossRef Kucukdeveci, A. A., Kutlay, S., Yildizlar, D., Oztuna, D., Elhan, A. H., & Tennant, A. (2013). The reliability and validity of the World Health Organization Disability Assessment Schedule (WHODAS-II) in stroke. Disability and Rehabilitation, 35(3), 214–220.PubMedCrossRef
19.
Zurück zum Zitat Zhao, H. P., Liu, Y., Li, H. L., Ma, L., Zhang, Y. J., & Wang, J. (2013). Activity limitation and participation restrictions of breast cancer patients receiving chemotherapy: Psychometric properties and validation of the Chinese version of the WHODAS 2.0. Quality of Life Research, 22(4), 897–906.PubMedCrossRef Zhao, H. P., Liu, Y., Li, H. L., Ma, L., Zhang, Y. J., & Wang, J. (2013). Activity limitation and participation restrictions of breast cancer patients receiving chemotherapy: Psychometric properties and validation of the Chinese version of the WHODAS 2.0. Quality of Life Research, 22(4), 897–906.PubMedCrossRef
20.
Zurück zum Zitat Downing, N. R., Kim, J. I., Williams, J. K., Long, J. D., Mills, J. A., & Paulsen, J. S. (2014). WHODAS 2.0 in prodromal Huntington disease: Measures of functioning in neuropsychiatric disease. European Journal of Human Genetics, 22, 958–963. Downing, N. R., Kim, J. I., Williams, J. K., Long, J. D., Mills, J. A., & Paulsen, J. S. (2014). WHODAS 2.0 in prodromal Huntington disease: Measures of functioning in neuropsychiatric disease. European Journal of Human Genetics, 22, 958–963.
21.
Zurück zum Zitat Guilera, G., Gomez-Benito, J., Pino, O., Rojo, J. E., Cuesta, M. J., Martinez-Aran, A., et al. (2012). Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia. Schizophrenia Research, 138(2–3), 240–247.PubMedCrossRef Guilera, G., Gomez-Benito, J., Pino, O., Rojo, J. E., Cuesta, M. J., Martinez-Aran, A., et al. (2012). Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia. Schizophrenia Research, 138(2–3), 240–247.PubMedCrossRef
22.
Zurück zum Zitat Schippers, G. M., Broekman, T. G., Buchholz, A., Koeter, M. W., & van den Brink, W. (2010). Measurements in the Addictions for Triage and Evaluation (MATE): An instrument based on the World Health Organization family of international classifications. Addiction, 105(5), 862–871.PubMedCrossRef Schippers, G. M., Broekman, T. G., Buchholz, A., Koeter, M. W., & van den Brink, W. (2010). Measurements in the Addictions for Triage and Evaluation (MATE): An instrument based on the World Health Organization family of international classifications. Addiction, 105(5), 862–871.PubMedCrossRef
23.
Zurück zum Zitat Kim, J. I., Long, J. D., Mills, J. A., Downing, N., Williams, J. K., Paulsen, J. S., the Predict-HD Investigators, & Group, t. C. o. t. H. S. (in press). Performance of the 12-item WHODAS 2.0 in prodromal Huntingon disease. European Journal of Human Genetics. Kim, J. I., Long, J. D., Mills, J. A., Downing, N., Williams, J. K., Paulsen, J. S., the Predict-HD Investigators, & Group, t. C. o. t. H. S. (in press). Performance of the 12-item WHODAS 2.0 in prodromal Huntingon disease. European Journal of Human Genetics.
24.
Zurück zum Zitat Sousa, R. M., Dewey, M. E., Acosta, D., Jotheeswaran, A. T., Castro-Costa, E., Ferri, C. P., et al. (2010). Measuring disability across cultures–the psychometric properties of the WHODAS II in older people from seven low- and middle-income countries. The 10/66 Dementia Research Group population-based survey. International Journal of Methods in Psychiatric Research, 19(1), 1–17.PubMedCentralPubMed Sousa, R. M., Dewey, M. E., Acosta, D., Jotheeswaran, A. T., Castro-Costa, E., Ferri, C. P., et al. (2010). Measuring disability across cultures–the psychometric properties of the WHODAS II in older people from seven low- and middle-income countries. The 10/66 Dementia Research Group population-based survey. International Journal of Methods in Psychiatric Research, 19(1), 1–17.PubMedCentralPubMed
25.
Zurück zum Zitat Andrews, G., Kemp, A., Sunderland, M., Von Korff, M., & Ustun, T. B. (2009). Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS ONE, 4(12), e8343.PubMedCentralPubMedCrossRef Andrews, G., Kemp, A., Sunderland, M., Von Korff, M., & Ustun, T. B. (2009). Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS ONE, 4(12), e8343.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091.PubMedCrossRef Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091.PubMedCrossRef
27.
Zurück zum Zitat Ho, L. W., Carmichael, J., Swartz, J., Wyttenbach, A., Rankin, J., & Rubinsztein, D. C. (2001). The molecular biology of Huntington’s disease. Psychological Medicine, 31(1), 3–14.PubMedCrossRef Ho, L. W., Carmichael, J., Swartz, J., Wyttenbach, A., Rankin, J., & Rubinsztein, D. C. (2001). The molecular biology of Huntington’s disease. Psychological Medicine, 31(1), 3–14.PubMedCrossRef
28.
Zurück zum Zitat Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., et al. (2006). Preparing for preventive clinical trials: The predict-HD study. Archives of Neurology, 63(6), 883–890.PubMedCrossRef Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., et al. (2006). Preparing for preventive clinical trials: The predict-HD study. Archives of Neurology, 63(6), 883–890.PubMedCrossRef
29.
Zurück zum Zitat Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., et al. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry, 79(8), 874–880.PubMedCentralPubMedCrossRef Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., et al. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry, 79(8), 874–880.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Shoulson, I., & Fahn, S. (1979). Huntington Disease—Clinical Care and Evaluation. Neurology, 29(1), 1–3.PubMedCrossRef Shoulson, I., & Fahn, S. (1979). Huntington Disease—Clinical Care and Evaluation. Neurology, 29(1), 1–3.PubMedCrossRef
31.
Zurück zum Zitat Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., et al. (2006). Preparing for preventive clinical trials—The Predict-HD study. Archives of Neurology, 63(6), 883–890.PubMedCrossRef Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., et al. (2006). Preparing for preventive clinical trials—The Predict-HD study. Archives of Neurology, 63(6), 883–890.PubMedCrossRef
32.
Zurück zum Zitat Hays, R. D., Sherbourn, C. D., & Mazel, R. (1995). User’s manual for the Medical Outcomes Study (MOS) core measures of health-related quality of life. Santa Monica, CA: RAND corporation. Hays, R. D., Sherbourn, C. D., & Mazel, R. (1995). User’s manual for the Medical Outcomes Study (MOS) core measures of health-related quality of life. Santa Monica, CA: RAND corporation.
33.
Zurück zum Zitat Feeny, D., Farris, K., Cote, I., Johnson, J. A., Tsuyuki, R. T., & Eng, K. (2005). A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients. Journal of Clinical Epidemiology, 58(2), 138–141.PubMedCrossRef Feeny, D., Farris, K., Cote, I., Johnson, J. A., Tsuyuki, R. T., & Eng, K. (2005). A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients. Journal of Clinical Epidemiology, 58(2), 138–141.PubMedCrossRef
34.
Zurück zum Zitat Johnson, J. A., & Maddigan, S. L. (2004). Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Quality of Life Research, 13(2), 449–456.PubMedCrossRef Johnson, J. A., & Maddigan, S. L. (2004). Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Quality of Life Research, 13(2), 449–456.PubMedCrossRef
35.
Zurück zum Zitat Maddigan, S. L., Feeny, D. H., Johnson, J. A., & Investigators, D. (2004). Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Quality of Life Research, 13(2), 435–448.PubMedCrossRef Maddigan, S. L., Feeny, D. H., Johnson, J. A., & Investigators, D. (2004). Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes. Quality of Life Research, 13(2), 435–448.PubMedCrossRef
36.
Zurück zum Zitat Selim, A. J., Rogers, W., Fleishman, J. A., Qian, S. X., Fincke, B. G., Rothendler, J. A., & Kazis, L. E. (2009). Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Quality of Life Research, 18(1), 43–52.PubMedCrossRef Selim, A. J., Rogers, W., Fleishman, J. A., Qian, S. X., Fincke, B. G., Rothendler, J. A., & Kazis, L. E. (2009). Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Quality of Life Research, 18(1), 43–52.PubMedCrossRef
37.
Zurück zum Zitat Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef
38.
Zurück zum Zitat Brazier, J. E., Walters, S. J., Nicholl, J. P., & Kohler, B. (1996). Using the SF-36 and Euroqol on an elderly population. Quality of Life Research, 5(2), 195–204.PubMedCrossRef Brazier, J. E., Walters, S. J., Nicholl, J. P., & Kohler, B. (1996). Using the SF-36 and Euroqol on an elderly population. Quality of Life Research, 5(2), 195–204.PubMedCrossRef
39.
Zurück zum Zitat Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., & Coons, S. J. (2005). Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Medical Care, 43(11), 1078–1086.PubMedCrossRef Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., & Coons, S. J. (2005). Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Medical Care, 43(11), 1078–1086.PubMedCrossRef
40.
Zurück zum Zitat Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., et al. (2007). US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care, 45(12), 1162–1170.PubMedCentralPubMedCrossRef Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., et al. (2007). US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Medical Care, 45(12), 1162–1170.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Johnson, J. A., & Coons, S. J. (1998). Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of Life Research, 7(2), 155–166.PubMedCrossRef Johnson, J. A., & Coons, S. J. (1998). Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of Life Research, 7(2), 155–166.PubMedCrossRef
42.
Zurück zum Zitat Dyer, M. T., Goldsmith, K. A., Sharples, L. S., & Buxton, M. J. (2010). A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes, 8, 13.PubMedCentralPubMedCrossRef Dyer, M. T., Goldsmith, K. A., Sharples, L. S., & Buxton, M. J. (2010). A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes, 8, 13.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Calvert, M. J., Freemantle, N., & Cleland, J. G. (2005). The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. European Journal of Heart Failure, 7(2), 243–251.PubMedCrossRef Calvert, M. J., Freemantle, N., & Cleland, J. G. (2005). The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. European Journal of Heart Failure, 7(2), 243–251.PubMedCrossRef
44.
Zurück zum Zitat Dorman, P., Slattery, J., Farrell, B., Dennis, M., & Sandercock, P. (1998). Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke, 29(1), 63–68.PubMedCrossRef Dorman, P., Slattery, J., Farrell, B., Dennis, M., & Sandercock, P. (1998). Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke, 29(1), 63–68.PubMedCrossRef
45.
Zurück zum Zitat Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997). Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). British Journal of Rheumatology, 36(5), 551–559.PubMedCrossRef Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997). Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). British Journal of Rheumatology, 36(5), 551–559.PubMedCrossRef
46.
Zurück zum Zitat Carlozzi, N. E., Miciura, A., Migliore, N., & Dayalu, P. (2014). Understanding the outcomes measures used in Huntington disease pharmacological trials: A systematic review. Journal of Huntington’s Disease, 3(3), 233–252.PubMedCentralPubMed Carlozzi, N. E., Miciura, A., Migliore, N., & Dayalu, P. (2014). Understanding the outcomes measures used in Huntington disease pharmacological trials: A systematic review. Journal of Huntington’s Disease, 3(3), 233–252.PubMedCentralPubMed
47.
Zurück zum Zitat Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). New York: Guilford Press. Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). New York: Guilford Press.
48.
Zurück zum Zitat Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107(2), 238–246.PubMedCrossRef Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107(2), 238–246.PubMedCrossRef
49.
Zurück zum Zitat Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling-A Multidisciplinary Journal, 6(1), 1–55.CrossRef Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling-A Multidisciplinary Journal, 6(1), 1–55.CrossRef
50.
Zurück zum Zitat Hatcher, L. (1994). A step-by-step approach to using SAS for factor analysis and structural equation modeling. Cary, NC: SAS Institute Inc. Hatcher, L. (1994). A step-by-step approach to using SAS for factor analysis and structural equation modeling. Cary, NC: SAS Institute Inc.
51.
Zurück zum Zitat Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.PubMedCrossRef Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.PubMedCrossRef
52.
Zurück zum Zitat Buist-Bouwman, M. A., Ormel, J., De Graaf, R., Vilagut, G., Alonso, J., Van Sonderen, E., & Vollebergh, W. A. (2008). Psychometric properties of the World Health Organization Disability Assessment Schedule used in the European Study of the Epidemiology of Mental Disorders. International Journal of Methods in Psychiatric Research, 17(4), 185–197.PubMedCrossRef Buist-Bouwman, M. A., Ormel, J., De Graaf, R., Vilagut, G., Alonso, J., Van Sonderen, E., & Vollebergh, W. A. (2008). Psychometric properties of the World Health Organization Disability Assessment Schedule used in the European Study of the Epidemiology of Mental Disorders. International Journal of Methods in Psychiatric Research, 17(4), 185–197.PubMedCrossRef
53.
Zurück zum Zitat Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225. Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225.
54.
Zurück zum Zitat Downing, N. R., Williams, J. K., & Paulsen, J. S. (2010). Couples’ attributions for work function changes in prodromal Huntington disease. Journal of Genetic Counseling, 19(4), 343–352.PubMedCentralPubMedCrossRef Downing, N. R., Williams, J. K., & Paulsen, J. S. (2010). Couples’ attributions for work function changes in prodromal Huntington disease. Journal of Genetic Counseling, 19(4), 343–352.PubMedCentralPubMedCrossRef
Metadaten
Titel
Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD)
verfasst von
Noelle E. Carlozzi
Anna L. Kratz
Nancy R. Downing
Siera Goodnight
Jennifer A. Miner
Nicholas Migliore
Jane S. Paulsen
Publikationsdatum
01.08.2015
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 8/2015
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-0930-x

Weitere Artikel der Ausgabe 8/2015

Quality of Life Research 8/2015 Zur Ausgabe